Award
BPA Call #75F40126F19011
Deloitte Consulting Awarded BPA Call for Drug Labeling Initiative Support
Buyer
Food and Drug Administration
Award Amount
$11,316,217.60
Ceiling
$19,761,293.40
Awarded
September 20, 2026
Period of Performance
Sep 20, 2026 – Sep 19, 2027
Identifier
75F40126F19011
NAICS
541990
This contract represents a Blanket Purchase Agreement (BPA) call awarded to Deloitte Consulting LLP, a premier consulting firm specializing in health and government services. The award supports the ongoing Drug Labeling Initiative, a critical effort to improve the safety, compliance, and clarity of drug labeling for public health and regulatory standards. Work performed under this BPA call includes delivering expert consulting services related to drug labeling enhancements, compliance assessments, and regulatory reporting. This initiative is significant for advancing industry standards and promoting consumer and healthcare professional confidence in drug information. The award was made through a competitive BPA vehicle, building on a prior multi-year Blanket Purchase Agreement established for the initiative. The contract covers a one-year base period with an option to extend for an additional year, reflecting a sustained commitment to supporting this important regulatory program. Performance will take place primarily at the Silver Spring, Maryland location.
Description
EO 14398